acetoacetates - CISMeF

Preferred Label : acetoacetates;

MeSH definition : Salts and derivatives of acetoacetic acid.;

Is substance : O;

Details

Origin ID

D000090;

UMLS CUI

C0000988;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Acetoacetate high [MedDRA LLT]
- Acetoacetate low [MedDRA LLT]
- Acetoacetic Acid Measurement [NCIt concept]
Record concept(s)
- acetoacetates [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,3-butanediol 1-monoacetoacetate [MeSH Supplementary Concept]
- 1,3-butanediol 3-monoacetoacetate [MeSH Supplementary Concept]
- 1,3-butanediol diacetoacetate [MeSH Supplementary Concept]
- 2-(methacryloyloxy)ethyl acetocetate [MeSH Supplementary Concept]
- 2-methacryloyloxymethyl acetoacetate [MeSH Supplementary Concept]
- 2-methylacetoacetic acid [MeSH Supplementary Concept]
- 2-octyl-gamma-bromoacetoacetate [MeSH Supplementary Concept]
- 4-(hydroxymethylphosphinoyl)-3-oxobutanoic acid [MeSH Supplementary Concept]
- A 21960 [MeSH Supplementary Concept]
- L 708906 [MeSH Supplementary Concept]
- L 731988 [MeSH Supplementary Concept]
- acetoacetic acid [MeSH Supplementary Concept]
- ethyl 2-((3,5-dimethylpyrazole-4-yl)hydrazono)-3-oxobutyrate [MeSH Supplementary Concept]
- ethyl 2-methyl acetoacetate [MeSH Supplementary Concept]
- ethyl 4,4,4-trifluoroacetoacetate [MeSH Supplementary Concept]
- ethyl 4,4-difluoro- 4-phenoxyacetoacetate [MeSH Supplementary Concept]
- ethyl 4-chloro-3-oxobutanoate [MeSH Supplementary Concept]
- ethyl acetoacetate [MeSH Supplementary Concept]
- fumarylacetoacetate [MeSH Supplementary Concept]
- methyl 2-((3,5-dimethylpyrazole-4-yl)hydrazono)4-methoxy-3-oxobutyrate [MeSH Supplementary Concept]
- methyl 2-anilinomethylene-3-oxobutanoate [MeSH Supplementary Concept]
- methyl acetoacetate [MeSH Supplementary Concept]
- monoacetoacetin [MeSH Supplementary Concept]
- octyl-4-chloroacetoacetate [MeSH Supplementary Concept]
- succinylacetoacetate [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Acetoacetate [LOINC part]
- Acetoacetate [LOINC component]
Validated automatic mappings to BTNT
- Acetoacetate [LOINC component]
- Acetoacetate [MedDRA LLT]
- Acetoacetate (substance) [Inactive SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients